Medicines and treatments can’t be offered to medical institutions or pharmacies without approval of a regulatory agency. A clinical trial is a type of research that conducted with the cooperation of healthy volunteers or patients in order to receive approval from the regulatory agency.
Clinical trials are not limited to new drugs. If a drug is used overseas already, a clinical trial is still needed before it can be used in Japan. Maybe the word of “clinical trials” is not so familiar to you, but it is not something new. It has a set of well-established system with a long history, and developed with the progress of modern medicine.
The ingredients of the medicine are derived from chemical synthesis, unknown substances such as bacteria in plants or soil, marine organisms and so on. In order to confirm effectiveness and safety, the substances will be tested by repeating animal experiments.
However, since these are something used on the human body, it is still necessary to evaluate the efficiency and safety on humans as a “drug candidate (study drug)”.
Clinical trials are conducted in all developed countries. The globally uniform standards which emphasize the accuracy of clinical trials and respect for human rights have been formed. In developed countries where volunteerism has developed, there is a growing awareness that “clinical trials” is a necessity for society, similar to “donating blood”.
Assuming that there are 100 new drugs have been developed in the world, 80-95 of them are already used in many developed countries whereas only 15-20 of them are used in Japan. The present situation in Japan is that people are not aware of the "clinical trials" and refuse to cooperate, thus the birth of new drugs is delayed.
By increasing the number of people who understand "clinical trials" could speed up the development of new drugs which would be provided to the patients suffering from illness in the world.
Let's look at what clinical trials do in the process.
Developing a new drug may take 10 years or more. During the long years, what role does the “clinical trials” play in the development? Let's check and understand it by according to the following explanation.
In this stage, researches will be carried out in order to find substances which can be used in drugs from plants, scientific substances, and microorganisms
Animal testing is conducted to assess whether the substances are safe and effective. Before starting a clinical trial, the efficacy and safety must have been confirmed in the animal testing.
Aim to evaluate safety using a few healthy adults as research subjects.
Aim to assess the efficacy and safety of the candidate drug with the cooperation of a small number of patients.
In order to confirm the efficacy, safety and usage, the new drug will be compared the difference with existing drugs.
The regulation and control of new drugs in Japan has been based on the PMDA (Pharmaceuticals and Medical Devices Agency). In order to be recognized as a "drug", the application of a new drug must be approved by PMDA. The review process is stringent. Once the efficacy and safety is reviewed, a license will be issued.
After approved by PMDA, the new drug can be manufactured, sold and used. Information on efficacy and safety will be collected and analyzed continually while the drug used by patients.
In the process of a new drug development, it takes the longest time for clinical trials.
Clinical trials are so important that always be treated with the utmost caution.
Clinical trials are carried out with the volunteers who participate in voluntary action. Therefore, please carefully judge the merits and demerits of participating in clinical trials.
When a subject decides to participate in a clinical trial, he (she) should be fully explained about the clinical trial from all sides.
If the subject understands and expresses intent to participate in the clinical trial, he (she) should confirm it by written documents.
Informed consent is validated by a signed and dated consent document from the subject and the clinical investigator.
The contents that must be explained in a clinical trial are defined in GCP (Good Clinical Practice). And “The contents should be interpreted as simple as possible.”, “The questions from the subject should be answered fully” are also required in GCP.
Such clarifications are described in the consent statement.
* The abbreviation of clinical trial monitors. The person who monitors and confirms the trial is properly conducted or not during the clinical trial.
Such clarifications are described in the consent statement.
Clinical trial coordinators (CRC) can protect human rights of patients (subjects), promote clinical trials smoothly, pay attention to security and privacy and respond appropriately.
ASBO is a website that guides clinical trials as one of treatment options under the motto of “Building tomorrow’s healthcare”.
This website will provide an opportunity to receive the latest treatment with safe and secure support.